A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
Active, not recruiting · NCT05318573 · Registry updated 2025-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer | Advanced Non Small Cell Lung Cancer; Advanced Urothelial Carcinoma | Active, not recruiting | Phase 2 | 2025-09-04 | NCT05318573 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fujifilm Pharmaceuticals U.S.A., Inc. | 3 |
| Merck Sharp & Dohme LLC | 650 |
23 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.